On 28 May, 2020 ASLM’s LabCoP hosted the fourth session in a series about manufacturers of COVID-19 molecular diagnostic tools, featuring Abbott. Presentations were made by Dr Claudio Galli, Associate Director, Medical Scientific Affairs Global, Abbott Core Laboratory, and Dr Liane Bauer, Director, Professional Services EMEA, Abbott Core Laboratory. They covered topics including detection of COVID-19 with serology tests (IgM and IgG), surveillance analytics for the management of COVID-19, status regarding regulatory approval, performance, run time, and other technical considerations, and requirements/consumables not supplied with the test(s). Please follow the links posted here to view the recorded video session on ASLM’s YouTube channel, and download the presentation slides from the session. The Q&A for this session is pending. Please check back for updates.